Organon & Co.

Healthcare · Drug Manufacturers - General · United States

Last price 13.81 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 3.63B

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Organon & Co. develops and delivers women health solutions through prescription therapies and medical devices in the United States, Europe, Canada, Japan, rest of the Asia Pacific, China, Latin America, the Middle East, Russia, Africa, and internationally. The company's women’s health portfolio comprises contraception and fertility brands, such as Nexplanon, a long-acting reversible contraceptive; NuvaRing, a monthly vaginal contraceptive ring; Cerazette, Marvelon, and Mercilon to prevent pregnancy; Follistim AQ, which is used to promote develo...